Difference between revisions of "Alvocidib (Flavopiridol)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Oral chemotherapy" to "Category:Oral medications") |
Warner-admin (talk | contribs) m (Text replacement - "Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL)" to "Chronic lymphocytic leukemia (CLL/SLL)") |
||
| Line 5: | Line 5: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Acute myeloid leukemia]] | *[[Acute myeloid leukemia]] | ||
| − | *[[Chronic lymphocytic leukemia (CLL | + | *[[Chronic lymphocytic leukemia (CLL/SLL)]] |
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | *4/13/2007: Granted orphan status for treatment of [[Chronic lymphocytic leukemia (CLL | + | *4/13/2007: Granted orphan status for treatment of [[Chronic lymphocytic leukemia (CLL/SLL) | B-cell chronic lymphocytic leukemia (B-CLL)]] or prolymphocytic leukemia arising from CLL. |
*4/23/2014: Granted orphan designation for the treatment of patients with [[Acute myeloid leukemia | acute myeloid leukemia (AML)]] | *4/23/2014: Granted orphan designation for the treatment of patients with [[Acute myeloid leukemia | acute myeloid leukemia (AML)]] | ||
| Line 18: | Line 18: | ||
[[Category:Acute myeloid leukemia medications]] | [[Category:Acute myeloid leukemia medications]] | ||
| − | [[Category:Chronic lymphocytic leukemia (CLL | + | [[Category:Chronic lymphocytic leukemia (CLL/SLL) medications]] |
[[Category:Drugs FDA approved in 2007]] | [[Category:Drugs FDA approved in 2007]] | ||
[[Category:Orphan drug]] | [[Category:Orphan drug]] | ||
Revision as of 15:04, 14 October 2017
Mechanism of action
Flavonoid alkaloid CDK9 kinase inhibitor
Route: PO
Diseases for which it is used
History of changes in FDA indication
- 4/13/2007: Granted orphan status for treatment of B-cell chronic lymphocytic leukemia (B-CLL) or prolymphocytic leukemia arising from CLL.
- 4/23/2014: Granted orphan designation for the treatment of patients with acute myeloid leukemia (AML)